Document Detail

Hyperbaric oxygen: its application in cardiology: a historical perspective and personal journey.
MedLine Citation:
PMID:  19829177     Owner:  NLM     Status:  MEDLINE    
Hyperbaric oxygen (HBO) was first used by placing a patient with the "bends" in a pressure chamber and increasing the pressure to 3 atm with 100% oxygen. It was soon recognized that HBO could also facilitate wound healing in infected ischemic extremities. Before the pump oxygenator was developed, it was also shown to facilitate corrective surgery, especially in congenital heart disease. In 1997, after encouraging animal work, HBO therapy was used in conjunction with thrombolytics to reduce the magnitude of injury in patients with acute myocardial infarction. The benefit is probably due to the decrease in reperfusion injury, which has been shown to be a major cause of myocardial cell death when the culprit artery is opened with a catheter. The most recent development is to infuse saline saturated with HBO into the opened coronary artery immediately after angioplasty. An advantage of this treatment has been demonstrated in experimental animals and in man. Future applications of HBO treatment in cardiovascular disease await more research, but at this time it seems to have considerable promise.
Myrvin H Ellestad
Related Documents :
24895597 - Significance of soluble lectin-like oxidized ldl receptor-1 levels in systemic and coro...
8097627 - Myocardial uptake and release of lactate after high dose neurolept endotracheal intubat...
2521267 - Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary bl...
19276987 - Effects of levosimendan on the energy balance: preclinical and clinical evidence.
19247187 - Factors influencing clopidogrel efficacy in patients with stable coronary artery diseas...
19389787 - Renal and cardiac function for long-term (10 year) risk stratification after myocardial...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Cardiology in review     Volume:  17     ISSN:  1538-4683     ISO Abbreviation:  Cardiol Rev     Publication Date:    2009 Nov-Dec
Date Detail:
Created Date:  2009-10-15     Completed Date:  2010-01-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9304686     Medline TA:  Cardiol Rev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  280-2     Citation Subset:  IM    
Long Beach Memorial Heart & Vascular Institute, Long Beach Memorial Medical Center, Long Beach, CA, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects
Cardiovascular Surgical Procedures / adverse effects
Coronary Artery Disease / therapy
Hyperbaric Oxygenation*
Myocardial Infarction / therapy*
Myocardial Reperfusion Injury / therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Surgical approaches for the prevention and treatment of type 2 diabetes mellitus.
Next Document:  The emerging role of apelin in cardiovascular disease and health.